Fig. 2From: A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials studyLung cancer type distribution. Distribution of lung cancer types in the cohort of the later clinical trial. Subjects were enrolled between 2019-03-24 and 2021-03-09 in three medical centersBack to article page